Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Ligon

Showing results (21-30 of 324) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependenceAkitake Mukasa, Jill Wykosky, Keith L Ligon, et al.
Diagnostic Pathology|November 17, 2017
A novel GIT2-BRAF fusion in pilocytic astrocytomaJeffrey Helgager, Hart G Lidov, Navin R Mahadevan, et al.
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.
Annals of Neurology|September 6, 2007
Impaired human hippocampal neurogenesis after treatment for central nervous system malignanciesMichelle L Monje, Hannes Vogel, Marilyn Masek, et al.
Stem Cells (Dayton, Ohio)|January 8, 2014
Pten loss in Olig2 expressing neural progenitor cells and oligodendrocytes leads to interneuron dysplasia and leukodystrophyCécile L Maire, Shakti Ramkissoon, Marika Hayashi, et al.
Oncotarget|January 18, 2015
Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog levelJessian L Munoz, Vivian Rodriguez-Cruz, Shakti H Ramkissoon, et al.
JCO Precision Oncology|September 14, 2020
WNT-Activated Medulloblastomas With Hybrid Molecular SubtypesJeffrey Helgager, Peter Pytel, Varshini Vasudevaraja, et al.
Plos One|September 4, 2014
Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomasKarl Holmberg Olausson, Cecile L Maire, Sam Haidar, et al.
Molecular Therapy. Nucleic Acids|October 3, 2013
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred ChemosensitivityJessian L Munoz, Sarah A Bliss, Steven J Greco, et al.
Neuro-Oncology|January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncologyDaniel N Cagney, Joohee Sul, Raymond Y Huang, et al.
Pageof 33

Showing results (21-30 of 324) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependenceAkitake Mukasa, Jill Wykosky, Keith L Ligon, et al.
Diagnostic Pathology|November 17, 2017
A novel GIT2-BRAF fusion in pilocytic astrocytomaJeffrey Helgager, Hart G Lidov, Navin R Mahadevan, et al.
Neuro-Oncology|May 24, 2012
Current clinical development of PI3K pathway inhibitors in glioblastomaPatrick Y Wen, Eudocia Q Lee, David A Reardon, et al.
Annals of Neurology|September 6, 2007
Impaired human hippocampal neurogenesis after treatment for central nervous system malignanciesMichelle L Monje, Hannes Vogel, Marilyn Masek, et al.
Stem Cells (Dayton, Ohio)|January 8, 2014
Pten loss in Olig2 expressing neural progenitor cells and oligodendrocytes leads to interneuron dysplasia and leukodystrophyCécile L Maire, Shakti Ramkissoon, Marika Hayashi, et al.
Oncotarget|January 18, 2015
Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog levelJessian L Munoz, Vivian Rodriguez-Cruz, Shakti H Ramkissoon, et al.
JCO Precision Oncology|September 14, 2020
WNT-Activated Medulloblastomas With Hybrid Molecular SubtypesJeffrey Helgager, Peter Pytel, Varshini Vasudevaraja, et al.
Plos One|September 4, 2014
Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomasKarl Holmberg Olausson, Cecile L Maire, Sam Haidar, et al.
Molecular Therapy. Nucleic Acids|October 3, 2013
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred ChemosensitivityJessian L Munoz, Sarah A Bliss, Steven J Greco, et al.
Neuro-Oncology|January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncologyDaniel N Cagney, Joohee Sul, Raymond Y Huang, et al.
Pageof 33